Total Payments
$1,660
2024 Payments
$118.62
Companies
18
Transactions
76
Medicare Patients
938
Medicare Billing
$50,992
Payment Breakdown by Category
Food & Beverage$1,368 (82.4%)
Education$291.94 (17.6%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,368 | 72 | 82.4% |
| Education | $291.94 | 4 | 17.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Biotech, Inc. | $414.33 | 21 | $0 (2024) |
| ABBVIE INC. | $353.40 | 18 | $0 (2022) |
| Incyte Corporation | $199.04 | 6 | $0 (2023) |
| Dermavant Sciences, Inc. | $97.65 | 1 | $0 (2022) |
| Amgen Inc. | $94.52 | 3 | $0 (2021) |
| UCB, Inc. | $83.28 | 3 | $0 (2024) |
| Lilly USA, LLC | $81.90 | 5 | $0 (2022) |
| PFIZER INC. | $81.33 | 4 | $0 (2022) |
| Sun Pharmaceutical Industries Inc. | $52.79 | 3 | $0 (2022) |
| Regeneron Healthcare Solutions, Inc. | $47.38 | 3 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $118.62 | 2 | Janssen Biotech, Inc. ($99.99) |
| 2023 | $99.99 | 1 | Incyte Corporation ($99.99) |
| 2022 | $611.90 | 27 | ABBVIE INC. ($200.45) |
| 2021 | $829.29 | 46 | Janssen Biotech, Inc. ($259.06) |
All Payment Transactions
76 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/28/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Education | In-kind items and services | $99.99 | General |
| Category: Immunology | ||||||
| 02/15/2024 | UCB, Inc. | Bimzelx (Biological) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Immunology | ||||||
| 01/13/2023 | Incyte Corporation | — | Education | Cash or cash equivalent | $99.99 | General |
| 11/30/2022 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $97.65 | General |
| Category: DERMATOLOGY | ||||||
| 11/02/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $30.94 | General |
| Category: IMMUNOLOGY | ||||||
| 08/09/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $28.74 | General |
| Category: IMMUNOLOGY | ||||||
| 06/21/2022 | Sun Pharmaceutical Industries Inc. | Winlevi (Drug) | Food and Beverage | In-kind items and services | $15.75 | General |
| Category: Dermatology | ||||||
| 06/08/2022 | UCB, Inc. | Cimzia (Drug) | Food and Beverage | In-kind items and services | $26.94 | General |
| Category: Immunology | ||||||
| 05/25/2022 | PFIZER INC. | CIBINQO (Drug) | Food and Beverage | In-kind items and services | $26.65 | General |
| Category: Inflammation & Immunology | ||||||
| 05/17/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $18.58 | General |
| Category: IMMUNOLOGY | ||||||
| 05/10/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: IMMUNOLOGY | ||||||
| 04/27/2022 | Ortho Dermatologics, a division of Bausch Health US, LLC | JUBLIA (Drug), ARAZLO, DUOBRII | Food and Beverage | In-kind items and services | $12.63 | General |
| Category: Podiatry | ||||||
| 04/26/2022 | Journey Medical Corporation | QBREXZA (Drug), Accutane | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: Dermatology | ||||||
| 04/14/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $13.33 | General |
| Category: IMMUNOLOGY | ||||||
| 04/12/2022 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $20.10 | General |
| Category: Immunology | ||||||
| 04/06/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $15.75 | General |
| Category: Dermatology | ||||||
| 04/05/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $21.73 | General |
| Category: IMMUNOLOGY | ||||||
| 04/05/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $1.61 | General |
| Category: IMMUNOLOGY | ||||||
| 03/29/2022 | Novartis Pharmaceuticals Corporation | COSENTYX (Biological) | Food and Beverage | In-kind items and services | $16.36 | General |
| Category: IMMUNOLOGY | ||||||
| 03/22/2022 | Biofrontera Inc. | AMELUZ (Drug), BF-RhodoLED, XEPI | Food and Beverage | Cash or cash equivalent | $13.96 | General |
| Category: DERMATOLOGY | ||||||
| 03/14/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $29.20 | General |
| Category: IMMUNOLOGY | ||||||
| 03/08/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $16.40 | General |
| Category: IMMUNOLOGY | ||||||
| 03/01/2022 | Incyte Corporation | OPZELURA (Drug) | Food and Beverage | Cash or cash equivalent | $25.12 | General |
| Category: Dermatology | ||||||
| 02/23/2022 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.97 | General |
| Category: IMMUNOLOGY | ||||||
| 02/10/2022 | Janssen Biotech, Inc. | REMICADE (Biological), SIMPONI, SIMPONI ARIA | Food and Beverage | In-kind items and services | $12.55 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 59 | 66 | $13,520 | $3,377 |
| 2022 | 8 | 282 | 486 | $63,752 | $12,741 |
| 2021 | 8 | 300 | 595 | $79,375 | $19,608 |
| 2020 | 8 | 297 | 551 | $57,127 | $15,266 |
Total Patients
938
Total Services
1,698
Medicare Billing
$50,992
Procedure Codes
28
All Medicare Procedures & Services
28 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 18 | 22 | $3,960 | $1,093 | 27.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 14 | 16 | $3,120 | $847.86 | 27.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 13 | 14 | $3,570 | $757.40 | 21.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 14 | 14 | $2,870 | $678.85 | 23.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 70 | $13,631 | $2,755 | 20.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 39 | 44 | $11,821 | $2,542 | 21.5% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 25 | 31 | $8,431 | $1,902 | 22.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 53 | 61 | $9,842 | $1,578 | 16.0% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 30 | 30 | $7,347 | $1,302 | 17.7% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 47 | 220 | $3,412 | $899.47 | 26.4% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 19 | 19 | $4,948 | $887.74 | 17.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $4,319 | $875.47 | 20.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 49 | 67 | $17,889 | $4,618 | 25.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 56 | 82 | $15,088 | $4,206 | 27.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 35 | 41 | $11,152 | $2,671 | 24.0% |
| 17000 | Destruction of skin growth | Office | 2021 | 57 | 81 | $12,960 | $2,645 | 20.4% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 33 | 38 | $9,272 | $2,225 | 24.0% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 14 | 14 | $5,684 | $1,429 | 25.1% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 43 | 259 | $3,885 | $1,098 | 28.3% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 13 | 13 | $3,445 | $716.86 | 20.8% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 69 | 85 | $13,560 | $3,868 | 28.5% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 40 | 42 | $8,463 | $2,510 | 29.7% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 31 | 34 | $8,616 | $2,285 | 26.5% |
| 17000 | Destruction of skin growth | Office | 2020 | 54 | 65 | $8,975 | $2,001 | 22.3% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 24 | 27 | $5,993 | $1,756 | 29.3% |
About Joyce Brun, MPAS, PA-C
Joyce Brun, MPAS, PA-C is a Physician Assistant healthcare provider based in Latrobe, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 11/11/2014. The National Provider Identifier (NPI) number assigned to this provider is 1780080200.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Joyce Brun, MPAS, PA-C has received a total of $1,660 in payments from pharmaceutical and medical device companies, with $118.62 received in 2024. These payments were reported across 76 transactions from 18 companies. The most common payment nature is "Food and Beverage" ($1,368).
As a Medicare-enrolled provider, Brun has provided services to 938 Medicare beneficiaries, totaling 1,698 services with total Medicare billing of $50,992. Data is available for 4 years (2020–2023), covering 28 distinct procedure/service records.
Ad
Practice Information
- Specialty Physician Assistant
- Location Latrobe, PA
- Active Since 11/11/2014
- Last Updated 01/22/2018
- Taxonomy Code 363A00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1780080200
Products in Payments
- TREMFYA (Drug) $315.14
- SKYRIZI (Biological) $130.45
- RINVOQ (Biological) $114.83
- HUMIRA (Biological) $108.12
- REMICADE (Biological) $99.19
- OPZELURA (Drug) $99.05
- VTAMA (Drug) $97.65
- Enbrel (Biological) $94.52
- TALTZ (Drug) $81.90
- Cimzia (Drug) $64.65
- EUCRISA (Drug) $54.68
- DUPIXENT (Biological) $47.38
- Winlevi (Drug) $38.75
- AMELUZ (Drug) $32.09
- CIBINQO (Drug) $26.65
- ADBRY (Biological) $24.92
- Bimzelx (Biological) $18.63
- AMZEEQ (Drug) $17.11
- COSENTYX (Biological) $16.36
- Avar (Drug) $14.37
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Physician Assistant Doctors in Latrobe
Jarrett Dorazio, Pa-C, PA-C
Physician Assistant — Payments: $794.16
Physician Assistant $794.16
Kendall Pfeifer, Pa-C, PA-C
Physician Assistant — Payments: $307.81
Physician Assistant $307.81
Emily Fulton, Pa-C, PA-C
Physician Assistant — Payments: $285.90
Physician Assistant $285.90
Fred Hickle, P.a, P.A
Physician Assistant — Payments: $123.58
Physician Assistant $123.58
Julia Rife, Pa-C, PA-C
Physician Assistant — Payments: $31.05
Physician Assistant $31.05
Noah Belak, Pa-C, PA-C
Physician Assistant — Payments: $15.07
Physician Assistant $15.07